Cell-drug conjugates.
Wang Y, Shi J, Xin M, Kahkoska AR, Wang J, Gu Z.
Nat Biomed Eng. 2024 Nov;8(11):1347-1365. doi: 10.1038/s41551-024-01230-6. Epub 2024 Jul 1.
Antiphospholipid syndrome.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA.
Lancet. 2010 Oct 30;376(9751):1498-509. doi: 10.1016/S0140-6736(10)60709-X. Epub 2010 Sep 6.
Obstetric antiphospholipid syndrome.
Soto-Peleteiro A, Gonzalez-Echavarri C, Ruiz-Irastorza G.
Med Clin (Barc). 2024 Aug;163 Suppl 1:S14-S21. doi: 10.1016/j.medcli.2024.05.001.
Recent advances in lentiviral vectors for gene therapy.
Wang X, Ma C, Rodríguez Labrada R, Qin Z, Xu T, He Z, Wei Y.
Sci China Life Sci. 2021 Nov;64(11):1842-1857. doi: 10.1007/s11427-021-1952-5. Epub 2021 Jul 14.
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?
Andreoli L, Regola F, Caproli A, Crisafulli F, Fredi M, Lazzaroni MG, Nalli C, Piantoni S, Zatti S, Franceschini F, Tincani A.
Rheumatology (Oxford). 2024 Feb 6;63(SI):SI86-SI95. doi: 10.1093/rheumatology/kead537.
Systems Chronotherapeutics.
Ballesta A, Innominato PF, Dallmann R, Rand DA, Lévi FA.
Pharmacol Rev. 2017 Apr;69(2):161-199. doi: 10.1124/pr.116.013441.
Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis.
Zhang S, Zhang M, Li X, Li G, Yang B, Lu X, Gao Y, Sun F.
Molecules. 2022 Sep 14;27(18):5973. doi: 10.3390/molecules27185973.
Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.
Cervadoro A, Palomba R, Vergaro G, Cecchi R, Menichetti L, Decuzzi P, Emdin M, Luin S.
Front Bioeng Biotechnol. 2018 Nov 27;6:177. doi: 10.3389/fbioe.2018.00177. eCollection 2018.
[HIV and pregnancy].
Zweifel VB, Berger C, Nadal D, Grawe C.
Ther Umsch. 2014 Aug;71(8):498-502. doi: 10.1024/0040-5930/a000543.
Immunodeficiency: Gene therapy for primary immune deficiency.
Afzal SY, MacDougall MS, McGhee SA.
Allergy Asthma Proc. 2024 Sep 1;45(5):384-388. doi: 10.2500/aap.2024.45.240054.
